Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Cervical Adenocarcinoma 1

Interventions

pembrolizumab 116Carboplatin 46Nivolumab 45Paclitaxel 34Cyclophosphamide 34Cisplatin 32Gemcitabine 30atezolizumab 28Specimen Handling 26venetoclax 25Magnetic Resonance Spectroscopy 24Docetaxel 24fludarabine 23Pemetrexed 23Biopsy 22Bevacizumab 22Radiotherapy 21Ipilimumab 21Azacitidine 21Dexamethasone 19durvalumab 18Radiosurgery 18Fluorouracil 17Cetuximab 16Trastuzumab 15fludarabine phosphate 14Leucovorin 14Cytarabine 14tislelizumab 13Lenalidomide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Salpingo-oophorectomy × 1 year × Clear all
NCT01048853 2026-01-07

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

M.D. Anderson Cancer Center

Phase NA Terminated
137 enrolled 15 charts
Gynecologic

Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡